A patient with advanced hepatocellular carcinoma presents with severe hepatic impairment, elevated bilirubin, and ascites. Which nursing intervention is the highest priority to prevent further complications in this patient?

B) Monitor oxygen saturation and administer supplemental oxygen as needed.

A) Administer lactulose to prevent hepatic encephalopathy.

B) Monitor oxygen saturation and administer supplemental oxygen as needed.

C) Prepare the patient for paracentesis to relieve ascites pressure.

D) Educate the patient on a low-sodium diet to manage ascites.

A 58-year-old patient with advanced hepatocellular carcinoma presents with severe hepatic impairment, marked ascites, and suspected pulmonary metastasis. The patient is experiencing respiratory distress with low oxygen saturation and an increased respiratory rate. What is the priority nursing intervention to address the patient's respiratory compromise?

C) Position the patient in high Fowler's position to facilitate lung expansion.

A) Administer supplemental oxygen to maintain adequate oxygen saturation.

B) Prepare the patient for paracentesis to relieve abdominal pressure.

C) Position the patient in high Fowler's position to facilitate lung expansion.

D) Initiate diuretic therapy to reduce fluid overload and improve breathing.

A patient with known liver failure has shown rapid deterioration with signs of respiratory compromise, hypotension, and neurological decline. Despite fluid resuscitation, the patient remains hypotensive, tachycardic, and hypoxic. Which of the following actions should the nurse prioritize to address the immediate concerns for this patient?

A) Prepare for immediate intubation and mechanical ventilation to manage respiratory failure.

B) Administer vasopressors as ordered to stabilize blood pressure and improve perfusion.

C) Initiate high-flow nasal cannula oxygen therapy to improve oxygenation levels.

D) Consult with the palliative care team to discuss end-of-life care options with the family.

A patient with liver failure has experienced a rapid decline in clinical status over the past 48 hours. The patient presents with hypotension, tachycardia, worsening respiratory distress, and decreased oxygen saturation despite supplemental oxygen. Neurologically, the patient is increasingly lethargic with a GCS of 11 and elevated ammonia levels. Given this clinical picture, what is the priority nursing intervention to address the patient's immediate needs?

B) Prepare for emergent intubation and mechanical ventilation.

A) Increase the supplemental oxygen flow rate to 6L/min via nasal cannula.

B) Prepare for emergent intubation and mechanical ventilation.

C) Administer intravenous albumin to manage hypotension.

D) Initiate a continuous infusion of lactulose to reduce ammonia levels.

A patient with advanced hepatocellular carcinoma and portal hypertension has been admitted to the ICU with acute gastrointestinal bleeding due to suspected ruptured esophageal varices. Despite interventions, the patient remains hypotensive and requires vasopressor support. Given the patient's critical status, what should be the priority nursing intervention?

C) Engage the interdisciplinary team to initiate discussions about transitioning to comfort-focused care.

A) Prepare the patient for an immediate endoscopic procedure to achieve hemostasis.

B) Administer a bolus of intravenous fluids to improve hemodynamic stability before any procedure.

C) Engage the interdisciplinary team to initiate discussions about transitioning to comfort-focused care.

D) Continue monitoring and adjust vasopressor support while preparing for possible surgical intervention.

A patient with advanced hepatocellular carcinoma and portal hypertension is experiencing acute gastrointestinal bleeding and has been transferred to the ICU. Despite interventions, the patient remains hypotensive with a significant drop in hemoglobin levels. Which of the following actions should the nurse prioritize to stabilize the patient's condition in this scenario?

B) Increase the dose of norepinephrine to improve blood pressure

A) Administer an additional unit of packed red blood cells immediately

B) Increase the dose of norepinephrine to improve blood pressure

C) Prepare the patient for urgent endoscopic intervention

D) Collaborate with the interdisciplinary team to discuss transitioning to comfort-focused care

A patient with worsening renal function, as indicated by an increase in serum creatinine levels to 2.4 mg/dL and lactate levels of 4.5 mmol/L, is critically ill and dependent on norepinephrine infusion. The patient now requires a non-rebreather mask to maintain oxygen saturation at 89%. Given the potential onset of respiratory compromise and acute kidney injury, what is the most appropriate immediate nursing intervention?

D) Prepare for possible intubation and mechanical ventilation.

A) Increase the norepinephrine infusion rate to further stabilize blood pressure.

B) Initiate continuous renal replacement therapy (CRRT) to address acute kidney injury.

C) Administer a diuretic to manage potential fluid overload.

D) Prepare for possible intubation and mechanical ventilation.

A critically ill patient with a history of liver cirrhosis is experiencing respiratory compromise and acute kidney injury following aggressive interventions, including norepinephrine infusion. The patient is on a non-rebreather mask with an oxygen saturation of 89%, and serum creatinine has doubled, indicating renal deterioration. What is the most appropriate nursing action to address the current clinical priorities?

B) Initiate a discussion with the healthcare team about the potential for renal replacement therapy.

A) Increase the norepinephrine infusion rate to further stabilize blood pressure.

B) Initiate a discussion with the healthcare team about the potential for renal replacement therapy.

C) Administer a diuretic to manage potential fluid overload and improve respiratory status.

D) Collaborate with the healthcare provider to consider switching to a high-flow nasal cannula for better oxygenation.

A patient with hepatic decompensation, renal insufficiency, and elevated INR is presenting with bilateral pleural effusions, pulmonary edema, significant ascites, and portal vein thrombosis. Considering the patient's coagulopathy and risk of bleeding, which of the following interventions should the nurse prioritize to stabilize the patient's condition while awaiting further interdisciplinary team decisions?

C) Monitor for signs of bleeding and withhold anticoagulation therapy until further evaluation.

A) Administer diuretics to manage fluid overload and improve respiratory status.

B) Prepare for urgent paracentesis to relieve ascites and improve hemodynamics.

C) Monitor for signs of bleeding and withhold anticoagulation therapy until further evaluation.

D) Initiate antibiotics empirically to address potential sepsis and prevent further deterioration.

A patient with hepatic decompensation, renal insufficiency, and portal vein thrombosis presents with respiratory compromise. Given the patient's elevated INR of 2.8, significant ascites, and pulmonary edema, what is the most appropriate initial nursing intervention to address the patient's respiratory status while also considering their coagulopathy?

C) Elevate the head of the bed to enhance oxygenation and support respiratory effort.

A) Administer a diuretic to reduce fluid overload and improve respiratory function.

B) Prepare for thoracentesis to relieve pleural effusions and improve breathing.

C) Elevate the head of the bed to enhance oxygenation and support respiratory effort.

D) Initiate oxygen therapy to address hypoxia and monitor respiratory status closely.

hepatocellular carcinoma - Nursing Case Study

Pathophysiology

• Primary mechanism: Chronic liver inflammation, often due to hepatitis B or C infections, leads to continuous hepatocyte injury and regeneration, promoting genetic mutations and malignant transformation of liver cells.

• Secondary mechanism: Cirrhosis, a common precursor, creates a fibrotic environment that disrupts normal blood flow and cellular architecture, further facilitating oncogenic processes and tumor development.

• Key complication: Advanced hepatocellular carcinoma can result in liver failure due to extensive tumor burden, portal hypertension, and metastasis, severely impacting liver function and leading to life-threatening complications.

Patient Profile

Demographics:

62-year-old male, retired chemical engineer

History:

• Key past medical history: Chronic Hepatitis C, Cirrhosis, Type 2 Diabetes Mellitus

• Current medications: Metformin, Entecavir, Insulin, Losartan, Lactulose

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Severe abdominal pain and jaundice

• Key symptoms: Abdominal distension, nausea, vomiting, unintentional weight loss, confusion, peripheral edema

• Vital signs: Blood pressure 90/60 mmHg, heart rate 120 bpm, respiratory rate 28 breaths per minute, temperature 38.5°C, oxygen saturation 88% on room air

Section 1

New Diagnostic Results:

Following the initial assessment, a series of diagnostic tests were conducted to gain a clearer understanding of the patient's current condition and underlying complications. Laboratory results revealed a significantly elevated alpha-fetoprotein (AFP) level, consistent with advanced hepatocellular carcinoma. Liver function tests indicated severe hepatic impairment, with markedly high bilirubin levels (total bilirubin: 18 mg/dL), elevated liver enzymes (AST: 220 U/L, ALT: 180 U/L), and reduced albumin levels (2.4 g/dL), suggesting both acute and chronic liver dysfunction. Coagulation profiles showed a prolonged prothrombin time (PT: 25 seconds), indicating compromised synthetic function of the liver.

Imaging studies, including an abdominal CT scan, confirmed the presence of multiple large hepatic masses with evidence of vascular invasion, consistent with aggressive tumor growth. Additionally, the scan revealed significant ascites and splenomegaly, indicative of portal hypertension. There was also suspicion of pulmonary metastasis, raising concerns about respiratory compromise given the patient's low oxygen saturation and increased respiratory rate. The CT findings, combined with the laboratory results, suggest a rapidly progressing hepatocellular carcinoma with systemic implications, requiring immediate and complex management strategies.

These diagnostic results highlight the critical need for aggressive intervention, including potential palliative care measures to manage symptoms and improve quality of life. The patient's condition is precarious, necessitating close monitoring for further complications such as hepatic encephalopathy or variceal bleeding. The healthcare team must employ advanced clinical judgment to prioritize interventions, balancing the management of hepatic failure, cardiovascular stability, and symptom control in the context of the patient's overall prognosis.

Section 2

Change in Patient Status:

The patient's clinical status has deteriorated rapidly over the past 48 hours, presenting new challenges in management. Vital signs reveal hypotension with blood pressure readings fluctuating between 85/50 mmHg and 90/55 mmHg, despite fluid resuscitation efforts. Tachycardia persists with a heart rate of 115-125 bpm, and tachypnea has worsened, with a respiratory rate now consistently above 30 breaths per minute. Oxygen saturation levels have decreased further, averaging around 88% on 4L/min of supplemental oxygen via nasal cannula, indicating potential respiratory compromise. The patient is visibly distressed, exhibiting signs of increased work of breathing, including the use of accessory muscles and nasal flaring.

Neurologically, the patient is becoming increasingly lethargic, a change from their baseline alert and oriented state. The Glasgow Coma Scale score has dropped to 11, raising concerns about the potential onset of hepatic encephalopathy, particularly in the context of elevated ammonia levels noted in the lab results (ammonia: 150 µmol/L). Physical examination reveals worsening jaundice and an increase in abdominal distension, with tense ascites and shifting dullness. Additionally, asterixis is noted, further indicating neurological impairment due to liver failure.

Given these developments, the healthcare team is confronted with the urgent need to stabilize the patient while also preparing for potential acute complications such as variceal bleeding or respiratory failure. Collaborative discussions with the oncology, hepatology, and palliative care teams are crucial to determine the most appropriate course of action. The patient's deteriorating condition requires reassessment of current interventions, possible escalation of care, and a review of goals of care with the patient and family, considering the poor prognosis and focus on quality of life.

Section 3

New Complications:

As the healthcare team continues to monitor the patient closely, new complications have arisen, compounding the already challenging clinical picture. Over the past 12 hours, there has been a sudden onset of melena and hematemesis, suggesting acute gastrointestinal bleeding, likely secondary to ruptured esophageal varices, a common complication of advanced hepatocellular carcinoma with portal hypertension. The patient's hemoglobin levels have dropped precipitously from 10 g/dL to 7 g/dL, necessitating an urgent transfusion of packed red blood cells. Coagulation profiles reveal an INR of 2.5, indicating significant coagulopathy, which further complicates the management of the bleeding and heightens the risk of further hemorrhagic events.

In response to these developments, the patient has been transferred to the intensive care unit for closer monitoring and aggressive intervention. The healthcare team has initiated an infusion of octreotide to reduce splanchnic blood flow and minimize variceal pressure, while also administering intravenous proton pump inhibitors to protect the gastric mucosa. Despite these efforts, the patient's hypotension remains refractory, and vasopressor support with norepinephrine has been initiated to maintain perfusion. The team faces the critical decision of whether to proceed with endoscopic intervention to achieve hemostasis or to prioritize stabilization given the patient's unstable hemodynamic status and poor overall prognosis.

This acute bleeding episode has prompted an urgent reassessment of the patient's goals of care. Discussions with the family are underway to address the potential transition to comfort-focused care, exploring the balance between aggressive interventions and the patient's quality of life. The interdisciplinary team, including palliative care specialists, is actively involved in guiding these conversations, ensuring that all decisions align with the patient's wishes and clinical realities. The complexity of the case requires continuous evaluation and adaptation of the care plan, reflecting the dynamic nature of the patient's condition and the need for nuanced clinical judgment.

Section 4

Change in Patient Status:

In the hours following the aggressive interventions, the patient's condition has shown a mix of subtle improvements and concerning developments. The norepinephrine infusion has helped to stabilize the patient's blood pressure, now maintaining at 90/60 mmHg, but the patient remains critically ill and dependent on vasopressor support. The patient's heart rate has decreased slightly to 110 beats per minute, which is a positive sign in the context of previous tachycardia. However, the patient's respiratory status has deteriorated, with an increased requirement for oxygen supplementation. The patient is now on a non-rebreather mask, maintaining oxygen saturation at 89%, indicating the potential onset of respiratory compromise possibly due to fluid overload or further hepatic decompensation.

Laboratory results reveal worsening renal function, with serum creatinine levels rising from 1.2 mg/dL to 2.4 mg/dL, suggestive of acute kidney injury, likely secondary to the ongoing hemodynamic instability and possibly hepatorenal syndrome. Lactate levels have also increased to 4.5 mmol/L, reflecting tissue hypoperfusion and raising concerns about the overall metabolic state. Despite the blood transfusion, the patient's hemoglobin has only modestly improved to 7.5 g/dL, highlighting the ongoing risk of bleeding and the limited efficacy of current hemostatic efforts.

Given these developments, the healthcare team must urgently re-evaluate the current treatment strategy, weighing the potential benefits and risks of further invasive procedures against the backdrop of the patient's declining organ function. Discussions continue with the patient's family regarding the realism of recovery versus the potential focus on palliative measures. The complexity of the patient's evolving status demands constant vigilance and readiness to pivot the care plan, as the team endeavors to align clinical actions with the patient's values and prognosis.

Section 5

New Diagnostic Results:

The healthcare team proceeded with a series of advanced diagnostic tests to further elucidate the underlying causes of the patient's deteriorating condition. A computed tomography (CT) scan of the chest revealed bilateral pleural effusions, more pronounced on the right side, which likely contributed to the patient's respiratory compromise. Additionally, the scan showed signs of pulmonary edema, indicative of fluid overload, a common complication in the context of hepatic decompensation and renal insufficiency. An abdominal ultrasound was performed, confirming significant ascites and revealing new evidence of portal vein thrombosis, complicating the already delicate hemodynamic situation.

Laboratory results painted a concerning picture of the patient's coagulopathy. The international normalized ratio (INR) was elevated at 2.8, despite previous administration of fresh frozen plasma, underscoring the liver's impaired synthetic function. Moreover, the patient's bilirubin levels were significantly elevated at 15 mg/dL, reflecting severe hepatic dysfunction. Inflammatory markers, such as C-reactive protein (CRP), were markedly increased, suggesting a possible infectious process or an exacerbation of the underlying malignancy.

These new findings prompted the interdisciplinary team to re-evaluate the therapeutic approach. The presence of portal vein thrombosis raised the question of anticoagulation therapy, which had to be carefully balanced against the risk of bleeding due to the patient's coagulopathy. Given the evidence of fluid overload, the potential for renal replacement therapy was discussed to manage the patient's acute kidney injury and fluid status. The team also considered initiating antibiotics empirically to address the potential for sepsis, which could further complicate the patient's fragile state. These decisions required careful deliberation and close monitoring, as the team navigated the complexities of the patient's rapidly evolving clinical scenario.